ENSAT Stage III Adrenal Cortex Carcinoma Clinical Trials in Dijon

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence